Using plasma amyloid oligomer to screen Alzheimer's disease
Higher plasma concentrations of Aβ oligomers were significantly associated with Alzheimer's disease (AD) compared to non-demented controls. This suggests that Aβ oligomers(AβO) can be potential plasma biomarkers to screen AD. However, a study recruiting more individuals is necessary to examine the association.
Authors
- Yuan Yang
- Jiaying Yang
- Pin‐Chieh Hsu
Institutions
- Kaohsiung Medical University (TW)
- Kaohsiung Medical University Chung-Ho Memorial Hospital (TW)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70856_099790
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00